The 2021-2026 UI Health Care Strategic Plan is a robust, yet flexible, plan focusing on initiatives that allow for continued success in carrying out the tripartite mission of education, research, and patient care. More information about the plan is available by clicking on the links below.
The ICTS is one of 60 leading medical research institutions located throughout the nation participating in the Clinical and Translational Science Award Consortium and is supported in part by award number 2 UL1 TR000442-06 from the National Center for Advancing Translational Sciences, and the National Institutes of Health. Our combined resources, efforts, and commitment are transforming how biomedical research is conducted by accelerating the translation of medical discoveries into actual treatments, engaging communities in clinical research efforts, and training new clinical and translational investigators.
The mission of this new institute is to understand the fundamentals of biology and disease and to extend our discoveries into real-life applications that improve human health. The hub of the Institute will be in the new Pappajohn Biomedical Discovery Building.
The IIHG is dedicated to promoting clinical care, research, and education focused on the medical and scientific significance of variation in the human genome. The IIHG is a statewide resource for understanding the extent and meaning of human DNA sequence variations.
The mission of the IIBI is to foster efficient and cooperative multidisciplinary and cross-college research and discovery in biomedical imaging, and to improve training and education.